3 курс / Фармакология / Лекарственные_средства,_применяемые_в_акушерстве_и_гинекологии,
.pdfɁɚɛɨɥɟɜɚɧɢɟ, |
|
Ʌɟɤɚɪɫɬɜɟɧɧɵɟ |
Ɋɚɡɨɜɚɹ |
ɋɭɬɨɱɧɚɹ |
ɋɩɨɫɨɛ |
Ⱦɥɢɬɟɥɶɧɨɫɬɶ |
ɉɪɢɦɟɱɚɧɢɟ |
ɨɫɧɨɜɧɨɣ |
|
ɩɪɟɩɚɪɚɬɵ (Ʌɋ) |
ɞɨɡɚ |
ɞɨɡɚ |
ɜɜɟɞɟɧɢɹ |
ɬɟɪɚɩɢɢ |
|
ɜɨɡɛɭɞɢɬɟɥɶ |
|
|
|
|
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
Ȼɢɮɢɞɨɛɚɤɬɟɪɢɧ ɮɨɪɬɟ |
2 ɞɨɡɵ |
6 ɞɨɡ |
ɜɧɭɬɪɶ |
10–12 ɫɭɬ |
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
«ɏɢɥɚɤ ɮɨɪɬɟ» |
5 ɦɥ |
15–20 ɦɥ |
ɜɧɭɬɪɶ |
10–12 ɫɭɬ |
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
«Ʌɢɧɟɤɫ» |
1 ɤɚɩɫɭɥɚ |
3 ɤɚɩɫɭɥɵ |
ɜɧɭɬɪɶ |
10–12 ɫɭɬ |
|
|
|
|
|
|
|
|
|
|
ɗɎɎȿɊȿɇɌɇɕȿ ɆȿɌɈȾɕ |
|
|
|
|
|
|
|
ɉɥɚɡɦɚɮɟɪɟɡ. |
|
|
|
|
|
|
|
Ⱦɥɹ ɟɝɨ ɨɛɟɫɩɟɱɟɧɢɹ — ɩɥɚɡɦɨɡɚɦɟɧɢɬɟɥɢ: |
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
Ȼɟɥɤɨɜɵɟ |
|
|
|
|
|
|
|
Ⱥɥɶɛɭɦɢɧ 10% ɪ-ɪ |
100 ɦɥ |
100– |
ɜ/ɜ ɤɚɩɟɥɶɧɨ |
2–3 ɪɚɡɚ |
|
|
|
|
|
200 ɦɥ |
|
|
|
|
|
Ʉɨɥɥɨɢɞɵ: |
|
|
|
|
|
|
|
Ƚɢɞɪɨɤɫɢɷɬɢɥɤɪɚɯɦɚɥ |
250–500 ɦɥ |
500 ɦɥ |
ɜ/ɜ ɤɚɩɟɥɶɧɨ |
2–3 ɫɭɬ |
|
|
|
6–10% ɪ-ɪ («Ɋɟɮɨɪɬɚɧ |
|
|
|
|
|
|
|
ȽɗɄ») |
|
|
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
Ⱦɟɤɫɬɪɚɧ [ɫɪɟɞɧɹɹ ɦɨ- |
400 ɦɥ |
400 ɦɥ |
ɜ/ɜ ɤɚɩɟɥɶɧɨ |
2–3 ɫɭɬ |
|
|
|
ɥɟɤɭɥɹɪɧɚɹ ɦɚɫɫɚ |
|
|
|
|
|
|
|
30 000–40 000] («Ɋɟɨ- |
|
|
|
|
|
|
|
ɩɨɥɢɝɥɸɤɢɧ») ɪ-ɪ |
|
|
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
ɉɨɜɢɞɨɧ 8000+ɧɚɬɪɢɹ |
200–400 ɦɥ |
200– |
ɜ/ɜ ɤɚɩɟɥɶɧɨ |
2–3 ɫɭɬ |
|
|
|
ɯɥɨɪɢɞ+ɤɚɥɢɹ ɯɥɨ- |
|
400 ɦɥ |
|
|
|
|
|
ɪɢɞ+ɤɚɥɶɰɢɹ ɯɥɨ- |
|
|
|
|
|
|
|
ɪɢɞ+ɦɚɝɧɢɹ ɯɥɨ- |
|
|
|
|
|
172
6 Раздел
Ɂɚɛɨɥɟɜɚɧɢɟ, |
|
Ʌɟɤɚɪɫɬɜɟɧɧɵɟ |
Ɋɚɡɨɜɚɹ |
ɋɭɬɨɱɧɚɹ |
ɋɩɨɫɨɛ |
Ⱦɥɢɬɟɥɶɧɨɫɬɶ |
ɉɪɢɦɟɱɚɧɢɟ |
ɨɫɧɨɜɧɨɣ |
|
ɩɪɟɩɚɪɚɬɵ (Ʌɋ) |
ɞɨɡɚ |
ɞɨɡɚ |
ɜɜɟɞɟɧɢɹ |
ɬɟɪɚɩɢɢ |
|
ɜɨɡɛɭɞɢɬɟɥɶ |
|
|
|
|
|
|
|
|
|
ɪɢɞ+ɧɚɬɪɢɹ ɝɢɞɪɨɤɚɪ- |
|
|
|
|
|
|
|
ɛɨɧɚɬ («Ƚɟɦɨɞɟɡ-ɇ») |
|
|
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
Ⱦɟɤɫɬɪɚɧ [ɫɪɟɞɧɹɹ ɦɨ- |
400 ɦɥ |
400 ɦɥ |
ɜ/ɜ ɤɚɩɟɥɶɧɨ |
2–3 ɫɭɬ |
|
|
|
ɥɟɤɭɥɹɪɧɚɹ ɦɚɫɫɚ |
|
|
|
|
|
|
|
50 000–70 000] («ɉɨɥɢ- |
|
|
|
|
|
|
|
ɝɥɸɤɢɧ») ɪ-ɪ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ʉɪɢɫɬɚɥɥɨɢɞɵ: |
|
|
|
|
|
|
|
ɇɚɬɪɢɹ ɯɥɨɪɢɞ |
400 ɦɥ |
400 ɦɥ |
ɜ/ɜ |
2–3 ɫɭɬ |
|
|
|
0,9% ɪ-ɪ |
|
|
|
|
|
|
|
Ⱥɧɬɢɤɨɚɝɭɥɹɧɬɵ: |
|
|
|
|
|
|
|
Ƚɟɩɚɪɢɧ ɧɚɬɪɢɹ |
5000–7500 ȿȾ |
5000– |
ɜ/ɜ |
3–5 ɫɭɬ |
|
|
|
|
|
7500 ȿȾ |
|
|
|
|
|
|
|
|
|
|
|
|
|
ɈȻɓȿɍɄɊȿɉɅəɘɓȺə |
ɌȿɊȺɉɂə |
|
|
|
|
|
(ɩɨɥɧɨɰɟɧɧɨɟ ɩɢɬɚɧɢɟ, ɜɢɬɚɦɢɧɨɬɟɪɚɩɢɹ, ɚɧɚɛɨɥɢɱɟɫɤɢɟ ɫɬɟɪɨɢɞɧɵɟ ɝɨɪɦɨɧɵ, ɩɪɢ ɧɟɨɛɯɨ- |
|
|||||
|
ɞɢɦɨɫɬɢ — ɞɨɩɨɥɧɢɬɟɥɶɧɨɟ ɩɚɪɟɧɬɟɪɚɥɶɧɨɟ ɩɢɬɚɧɢɟ ɫɩɟɰɢɚɥɶɧɵɦɢ ɫɦɟɫɹɦɢ) |
|
|||||
|
|
|
|||||
Ɉ85 ɉɟɪɢɬɨɧɢɬ |
Ʌɟɱɟɧɢɟ ɚɤɭɲɟɪɫɤɨɝɨ ɩɟɪɢɬɨɧɢɬɚ ɞɨɥɠɧɨ ɩɪɨɜɨɞɢɬɶɫɹ ɜ ɨɬɞɟɥɟɧɢɢ ɢɧɬɟɧɫɢɜɧɨɣ ɬɟɪɚɩɢɢ |
|
|||||
ȼɨɡɛɭɞɢɬɟɥɢ: |
ɢɥɢ ɪɟɚɧɢɦɚɰɢɢ ɫɨɜɦɟɫɬɧɨ ɚɤɭɲɟɪɨɦ, ɯɢɪɭɪɝɨɦ, ɪɟɚɧɢɦɚɬɨɥɨɝɨɦ ɢ ɬɟɪɚɩɟɜɬɨɦ |
|
|||||
ɚɫɫɨɰɢɚɰɢɢ |
|
|
|||||
ȺɇȿɋɌȿɁɂɈɅɈȽɂɑȿɋɄɈȿ ɉɈɋɈȻɂȿ ɉɊɂ ȻɈɅɖɒɂɏ ɈɉȿɊȺɐɂəɏ |
|
||||||
ɚɷɪɨɛɧɵɯ |
(ɷɤɫɬɢɪɩɚɰɢɹ ɦɚɬɤɢ) ɫɦ. ɪɚɡɞɟɥ «Ⱥɧɟɫɬɟɡɢɨɥɨɝɢɹ» |
|
|
|
|||
ɢ ɚɧɚɷɪɨɛɧɵɯ |
|
|
|
|
|
Ɉɫɧɨɜɧɵɟɩɪɢɧɰɢɩɵ |
|
ȺɇɌɂȻɂɈɌɂɄɂ |
|
|
|
|
|||
ɦɢɤɪɨɨɪɝɚɧɢɡ- |
I. Ɇɨɧɨɬɟɪɚɩɢɹ |
|
|
|
|
ɬɟɪɚɩɢɢɩɟɪɢɬɨɧɢɬɚ: |
|
ɦɨɜ: |
|
|
|
|
|
|
1) ɩɪɟɞɨɩɟɪɚɰɢɨɧɧɚɹ |
|
ɐɟɮɨɩɟɪɚ- |
2 ɝ |
4–8 ɝ |
ɜ/ɜ, ɜ/ɦ |
|
||
E. сoli, |
|
ɡɨɧ+ɫɭɥɶɛɚɤɬɚɦ |
|
|
|
|
ɩɨɞɝɨɬɨɜɤɚ; |
Proteus spp., |
|
(«ɋɭɥɶɩɟɪɚɡɨɧ») |
|
|
|
|
2) ɷɤɫɬɢɪɩɚɰɢɹɦɚɬɤɢɫ |
Klebsiella spp., |
|
ɢɥɢ |
|
|
|
|
ɬɪɭɛɚɦɢ, ɪɟɜɢɡɢɹ, |
|
|
|
|
|
|
|
|
173 ...заболеваний инфекционных терапии при применяемые ЛС,
Ɂɚɛɨɥɟɜɚɧɢɟ, |
|
Ʌɟɤɚɪɫɬɜɟɧɧɵɟ |
Ɋɚɡɨɜɚɹ |
ɋɭɬɨɱɧɚɹ |
ɋɩɨɫɨɛ |
Ⱦɥɢɬɟɥɶɧɨɫɬɶ |
ɉɪɢɦɟɱɚɧɢɟ |
ɨɫɧɨɜɧɨɣ |
|
ɩɪɟɩɚɪɚɬɵ (Ʌɋ) |
ɞɨɡɚ |
ɞɨɡɚ |
ɜɜɟɞɟɧɢɹ |
ɬɟɪɚɩɢɢ |
|
ɜɨɡɛɭɞɢɬɟɥɶ |
|
|
|
|
|
|
|
Pseudomonas |
|
ɐɟɮɟɩɢɦ («Ɇɚɤɫɢ- |
1–2 ɝ |
2–4 ɝ |
ɜ/ɜ, ɜ/ɦ |
|
ɫɚɧɚɰɢɹ, ɞɪɟɧɢɪɨɜɚɧɢɟ |
spp., |
|
ɩɢɦ») |
|
|
|
|
ɛɪɸɲɧɨɣɩɨɥɨɫɬɢ; |
Enterobacter |
|
ɢɥɢ |
|
|
|
|
3) ɤɨɦɩɥɟɤɫɧɚɹɬɟɪɚɩɢɹ |
spp., |
|
ɂɦɢɩɟɧɟɦ+ɰɢɥɚɫɬɚɬɢɧ |
1 ɝ |
2–4 ɝ |
ɜ/ɜ |
|
ɜɩɨɫɥɟɨɩɟɪɚɰɢɨɧɧɨɦ |
Enterococcus |
|
(«Ɍɢɟɧɚɦ») |
|
|
|
|
ɩɟɪɢɨɞɟ(ɫɦ. ɩɨɪɚɡɞɟ- |
spp., |
|
ɢɥɢ |
|
|
|
|
ɥɚɦ). Ⱦɥɢɬɟɥɶɧɨɫɬɶɥɟ- |
ɫɬɪɟɩɬɨɤɨɤɤɢ |
|
Ɇɟɪɨɩɟɧɟɦ («Ɇɟɪɨ- |
0,5 ɝ |
1,5–3 ɝ |
ɜ/ɜ |
|
ɱɟɧɢɹɨɩɪɟɞɟɥɹɟɬɫɹɢɧ- |
ɝɪɭɩɩɵ ȼ., |
|
ɧɟɦ») |
|
|
|
|
ɞɢɜɢɞɭɚɥɶɧɨ |
Staphylococcus |
ɢɥɢ |
|
|
|
|
|
|
spp., |
|
|
|
|
|
|
|
II. Ʉɨɦɛɢɧɢɪɨɜɚɧɧɚɹ ɬɟɪɚ- |
|
|
|
|
|
||
Сhlamidia tra- |
ɩɢɹ |
|
|
|
|
|
|
chomatis, |
|
|
|
|
|
|
|
|
ɐɟɮɨɬɚɤɫɢɦ («Ʉɥɚɮɨ- |
1–2 ɝ |
3–8 ɝ |
ɜ/ɜ, ɜ/ɦ |
|
|
|
Mycoplasma |
|
ɪɚɧ») |
|
|
|
|
|
hominis, |
|
ɢɥɢ |
|
|
|
|
|
Ureaplasma |
|
ɐɟɮɬɚɡɢɞɢɦ («Ɏɨɪ- |
1–2 ɝ |
4–6 ɝ |
ɜ/ɜ, ɜ/ɦ |
|
|
urealyticum ɢ |
|
ɬɭɦ») |
|
|
|
|
|
ɞɪ., |
|
ɢɥɢ |
|
|
|
|
|
Bacteroides spp., |
|
ɐɟɮɨɩɟɪɚɡɨɧ («ɐɟɮɨ- |
1–2 ɝ |
2–4 ɝ |
ɜ/ɜ |
|
|
Peptostreptococ- |
|
ɛɢɞ») |
|
|
|
|
|
cus spp., |
|
ɢɥɢ |
|
|
|
|
|
Fusobacterium |
|
ɐɟɮɬɪɢɚɤɫɨɧ («Ɋɨɰɟ- |
1–2 ɝ |
2–4 ɝ |
ɜ/ɜ |
|
|
spp., |
|
ɮɢɧ», «ɐɟɮɬɪɢɚɛɨɥ») |
|
|
|
|
|
Peptococcus spp. |
|
|
|
|
|
|
|
+ |
|
|
|
|
|
ɋɭɬɨɱɧɭɸ ɞɨɡɭ ɚɦɢ- |
|
ɢ ɞɪ. |
|
|
|
|
|
|
ɧɨɝɥɢɤɨɡɢɞɨɜ ɰɟɥɟɫɨ- |
|
Ƚɟɧɬɚɦɢɰɢɧ |
|
3–5 ɦɝ/ɤɝ/ɫ |
ɜ/ɦ |
|
||
|
|
ɢɥɢ |
|
|
|
|
ɨɛɪɚɡɧɨ ɜɜɨɞɢɬɶ ɜ 1–2 |
|
|
ɇɟɬɢɥɦɢɰɢɧ |
|
3–5 ɦɝ/ɤɝ/ɫ |
ɜ/ɦ |
|
ɩɪɢɟɦɚ |
|
|
|
|
|
|
|
|
174
6 Раздел
Ɂɚɛɨɥɟɜɚɧɢɟ, |
|
Ʌɟɤɚɪɫɬɜɟɧɧɵɟ |
Ɋɚɡɨɜɚɹ |
ɋɭɬɨɱɧɚɹ |
ɋɩɨɫɨɛ |
Ⱦɥɢɬɟɥɶɧɨɫɬɶ |
ɉɪɢɦɟɱɚɧɢɟ |
ɨɫɧɨɜɧɨɣ |
|
ɩɪɟɩɚɪɚɬɵ (Ʌɋ) |
ɞɨɡɚ |
ɞɨɡɚ |
ɜɜɟɞɟɧɢɹ |
ɬɟɪɚɩɢɢ |
|
ɜɨɡɛɭɞɢɬɟɥɶ |
|
|
|
|
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
Ⱥɦɢɤɚɰɢɧ |
|
15–20 |
ɜ/ɦ |
|
|
|
|
|
|
ɦɝ/ɤɝ/ɫ |
|
|
|
|
|
|
|
|
|
|
|
|
+ |
|
|
|
|
|
|
|
|
Ʉɥɢɧɞɚɦɢɰɢɧ |
0,3–0,6 ɝ |
0,9–1,8 ɝ |
ɜ/ɜ, ɜ/ɦ |
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
Ʌɢɧɤɨɦɢɰɢɧ |
0,6 ɝ |
1,8 ɝ |
ɜ/ɜ, ɜ/ɦ |
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
Ɇɟɬɪɨɧɢɞɚɡɨɥ |
0,5 ɝ |
1–1,5 ɝ |
ɜ/ɜ |
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
|
Ⱥɦɨɤɫɢɰɢɥ- |
1,2 ɝ |
3,6 ɝ |
ɜ/ɜ |
|
|
|
|
ɥɢɧ+ɤɥɚɜɭɥɚɧɨɜɚɹ ɤɢ- |
|
|
|
|
|
|
|
ɫɥɨɬɚ («Ⱥɦɨɤɫɢɤɥɚɜ», |
|
|
|
|
|
|
|
«Ⱥɭɝɦɟɧɬɢɧ») |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
+ |
|
|
|
|
|
|
|
|
Ⱥɦɢɤɚɰɢɧ |
|
15–20 ɦɝ/ɤɝ |
ɜ/ɦ |
Ⱦɥɢɬɟɥɶɧɨɫɬɶ ɥɟ- |
|
|
|
ɢɥɢ |
|
|
|
ɱɟɧɢɹ ɨɩɪɟɞɟɥɹ- |
|
|
|
Ƚɟɧɬɚɦɢɰɢɧ |
|
3–5 ɦɝ/ɤɝ |
ɜ/ɦ |
ɟɬɫɹ ɬɹɠɟɫɬɶɸ ɬɟ- |
|
|
|
ɢɥɢ |
|
|
|
ɱɟɧɢɹ ɩɚɬɨɥɨɝɢ- |
|
|
|
ɇɟɬɢɥɦɢɰɢɧ |
|
3–5 ɦɝ/ɤɝ |
ɜ/ɦ |
ɱɟɫɤɨɝɨ ɩɪɨɰɟɫɫɚ |
|
|
+ |
|
|
|
|
|
|
|
|
Ɇɟɬɪɨɧɢɞɚɡɨɥ |
0,5 ɝ |
1–1,5 ɝ |
ɜ/ɜ |
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
|
ɉɢɩɟɪɚɰɢɥ- |
2,24–4,5 ɝ |
6,75–13,5 ɝ |
ɜ/ɜ |
|
|
|
|
ɥɢɧ+ɬɚɡɨɛɚɤɬɚɦ |
|
|
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
|
|
|
|
|
|
175 ...заболеваний инфекционных терапии при применяемые ЛС,
Ɂɚɛɨɥɟɜɚɧɢɟ, |
|
Ʌɟɤɚɪɫɬɜɟɧɧɵɟ |
Ɋɚɡɨɜɚɹ |
ɋɭɬɨɱɧɚɹ |
ɋɩɨɫɨɛ |
Ⱦɥɢɬɟɥɶɧɨɫɬɶ |
ɉɪɢɦɟɱɚɧɢɟ |
ɨɫɧɨɜɧɨɣ |
|
ɩɪɟɩɚɪɚɬɵ (Ʌɋ) |
ɞɨɡɚ |
ɞɨɡɚ |
ɜɜɟɞɟɧɢɹ |
ɬɟɪɚɩɢɢ |
|
ɜɨɡɛɭɞɢɬɟɥɶ |
|
|
|
|
|
|
|
|
|
Ɍɢɤɚɪɰɢɥ- |
3,1 ɝ |
9,3 ɝ |
ɜ/ɜ |
|
|
|
|
ɥɢɧ+ɤɥɚɜɭɥɚɧɨɜɚɹ ɤɢ- |
|
|
|
|
|
|
|
ɫɥɨɬɚ («Ɍɢɦɟɧɬɢɧ») |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
+ |
|
|
|
|
|
|
|
|
Ⱥɦɢɤɚɰɢɧ |
|
15–20 ɦɝ/ɤɝ |
ɜ/ɦ |
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
Ƚɟɧɬɚɦɢɰɢɧ |
|
3–5 ɦɝ/ɤɝ |
ɜ/ɦ |
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
ɇɟɬɢɥɦɢɰɢɧ |
|
3–5 ɦɝ/ɤɝ |
ɜ/ɦ |
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
|
Ʌɟɜɨɮɥɨɤɫɚɰɢɧ («Ɍɚ- |
0,5 ɝ |
1 ɝ |
ɜ/ɜ |
|
|
|
|
ɜɚɧɢɤ») |
|
|
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
Ɉɮɥɨɤɫɚɰɢɧ («Ɍɚɪɢ- |
0,1–0,2 ɝ |
0,2–0,4 ɝ |
ɜ/ɜ |
|
|
|
|
ɜɢɞ») |
|
|
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
ɉɟɮɥɨɤɫɚɰɢɧ («Ⱥɛɚɤ- |
0,4 ɝ |
0,8 ɝ |
ɜ/ɜ |
|
|
|
|
ɬɚɥ») |
|
|
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
ɐɢɩɪɨɮɥɨɤɫɚɰɢɧ |
0,4 ɝ |
0,8 ɝ |
ɜ/ɜ |
|
|
|
|
(«Ʉɜɢɧɬɨɪ», «ɐɢɩɪɨ- |
|
|
|
|
|
|
|
ɛɚɣ», «ɐɢɩɪɨɥɟɬ») |
|
|
|
|
|
|
+ |
|
|
|
|
|
|
|
|
Ɇɟɬɪɨɧɢɞɚɡɨɥ |
0,5 ɝ |
1–1,5 ɝ |
ɜ/ɜ |
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
|
ɂɦɢɩɟɧɟɦ+ɰɢɥɚɫɬɚɬɢɧ |
0,5–1 ɝ |
1,5–2 ɝ |
ɜ/ɜ |
|
|
176
6 Раздел
Ɂɚɛɨɥɟɜɚɧɢɟ, |
|
Ʌɟɤɚɪɫɬɜɟɧɧɵɟ |
Ɋɚɡɨɜɚɹ |
ɋɭɬɨɱɧɚɹ |
ɋɩɨɫɨɛ |
Ⱦɥɢɬɟɥɶɧɨɫɬɶ |
ɉɪɢɦɟɱɚɧɢɟ |
ɨɫɧɨɜɧɨɣ |
|
ɩɪɟɩɚɪɚɬɵ (Ʌɋ) |
ɞɨɡɚ |
ɞɨɡɚ |
ɜɜɟɞɟɧɢɹ |
ɬɟɪɚɩɢɢ |
|
ɜɨɡɛɭɞɢɬɟɥɶ |
|
|
|
|
|
|
|
|
|
(«Ɍɢɟɧɚɦ») |
|
|
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
Ɇɟɪɨɩɟɧɟɦ («Ɇɟɪɨ- |
0,5–1 ɝ |
1,5–2 ɝ |
ɜ/ɜ |
|
|
|
|
ɧɟɦ») |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
+ |
|
|
|
|
|
|
|
|
Ʉɥɢɧɞɚɦɢɰɢɧ |
0,3–0,6 ɝ |
0,9–1,8 ɝ |
ɜ/ɜ, ɜ/ɦ |
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
Ɇɟɬɪɨɧɢɞɚɡɨɥ |
0,5 ɝ |
1,5 ɝ |
ɜ/ɜ |
|
|
|
|
|
|
|
|
|
|
|
|
ɉɊɈɎɂɅȺɄɌɂɄȺ ȽɊɂȻɄɈȼɈɃ ɋɍɉȿɊɂɇɎȿɄɐɂɂ |
|
|
|||
|
|
Ɏɥɭɤɨɧɚɡɨɥ («Ⱦɢɮɥɸ- |
0,1 ɝ |
0,1 ɝ |
ɜ/ɜ |
1 ɪɚɡ ɜ 5–7 ɫɭɬ |
|
|
|
ɤɚɧ», «Ɏɥɸɤɨɫɬɚɬ») |
|
|
|
|
|
|
|
ɢ ɜɧɭɬɪɶ |
0,15 ɝ |
0,15 ɝ |
ɜɧɭɬɪɶ |
1 ɪɚɡ ɜ 5–7 ɫɭɬ |
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
ɇɢɫɬɚɬɢɧ |
500 000 ȿȾ |
2 000 000– |
ɜɧɭɬɪɶ |
Ⱦɥɢɬɟɥɶɧɨɫɬɶ |
|
|
|
|
|
3 000 000 |
|
ɨɩɪɟɞɟɥɹɟɬɫɹ ɢɧ- |
|
|
|
|
|
ȿȾ |
|
ɞɢɜɢɞɭɚɥɶɧɨ |
|
|
|
|
|
|
|
|
|
|
|
ɄɈɆɉɅȿɄɋɇȺə ɂɇɎɍɁɂɈɇɇɈ-ɌɊȺɇɋɎɍɁɂɈɇɇȺə ɌȿɊȺɉɂə |
|
ɉɪɨɞɨɥɠɢɬɟɥɶɧɨɫɬɶ, |
|||
|
I. ɉɪɟɩɚɪɚɬɵ ɞɥɹ ɤɨɪɪɟɤɰɢɢ ɜɨɞɧɨ-ɷɥɟɤɬɪɨɥɢɬɧɵɯ ɧɚɪɭɲɟɧɢɣ: |
|
ɨɛɴɟɦ, ɫɨɫɬɚɜ ɢɧɮɭ- |
||||
|
|
|
|
|
|
|
ɡɢɨɧɧɨɣ ɬɟɪɚɩɢɢ ɨɩ- |
|
|
ɇɚɬɪɢɹ ɚɰɟɬɚɬ+ɧɚɬɪɢɹ |
400 ɦɥ |
400 ɦɥ |
ɜ/ɜ |
|
|
|
|
ɯɥɨɪɢɞ+ɤɚɥɢɹ ɯɥɨɪɢɞ |
|
|
|
|
ɪɟɞɟɥɹɸɬɫɹ ɨɫɨɛɟɧɧɨ- |
|
|
(«ɏɥɨɫɨɥɶ») |
|
|
|
|
ɫɬɹɦɢ ɬɟɱɟɧɢɹ ɩɚɬɨ- |
|
|
ɢɥɢ |
|
|
|
|
ɥɨɝɢɱɟɫɤɨɝɨ ɩɪɨɰɟɫɫɚ |
|
|
ɇɚɬɪɢɹ ɚɰɟɬɚɬ+ɧɚɬɪɢɹ |
400 ɦɥ |
400 ɦɥ |
ɜ/ɜ |
|
|
|
|
ɯɥɨɪɢɞ («Ⱦɢɫɨɥɶ») |
|
|
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
177 ...заболеваний инфекционных терапии при применяемые ЛС,
Ɂɚɛɨɥɟɜɚɧɢɟ, |
|
Ʌɟɤɚɪɫɬɜɟɧɧɵɟ |
Ɋɚɡɨɜɚɹ |
ɋɭɬɨɱɧɚɹ |
ɋɩɨɫɨɛ |
Ⱦɥɢɬɟɥɶɧɨɫɬɶ |
ɉɪɢɦɟɱɚɧɢɟ |
ɨɫɧɨɜɧɨɣ |
|
ɩɪɟɩɚɪɚɬɵ (Ʌɋ) |
ɞɨɡɚ |
ɞɨɡɚ |
ɜɜɟɞɟɧɢɹ |
ɬɟɪɚɩɢɢ |
|
ɜɨɡɛɭɞɢɬɟɥɶ |
|
|
|
|
|
|
|
|
|
ɇɚɬɪɢɹ ɝɢɞɪɨɤɚɪɛɨ- |
400 ɦɥ |
400 ɦɥ |
ɜ/ɜ |
|
|
|
|
ɧɚɬ+ɧɚɬɪɢɹ ɯɥɨ- |
|
|
|
|
|
|
|
ɪɢɞ+ɤɚɥɢɹ ɯɥɨɪɢɞ |
|
|
|
|
|
|
|
(«Ɍɪɢɫɨɥɶ») |
|
|
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
ɇɚɬɪɢɹ ɯɥɨɪɢɞɚ ɪɚɫ- |
400 ɦɥ |
400 ɦɥ |
ɜ/ɜ |
|
|
|
|
ɬɜɨɪ ɫɥɨɠɧɵɣ (ɤɚɥɢɹ |
|
|
|
|
|
|
|
ɯɥɨɪɢɞ+ɤɚɥɶɰɢɹ ɯɥɨ- |
|
|
|
|
|
|
|
ɪɢɞ+ɧɚɬɪɢɹ ɯɥɨɪɢɞ — |
|
|
|
|
|
|
|
ɪɚɫɬɜɨɪ Ɋɢɧɝɟɪɚ) |
|
|
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
ɇɚɬɪɢɹ ɥɚɤɬɚɬɚ ɪɚɫɬɜɨɪ |
400 ɦɥ |
400 ɦɥ |
ɜ/ɜ |
|
|
|
|
ɫɥɨɠɧɵɣ (ɤɚɥɢɹ ɯɥɨ- |
|
|
|
|
|
|
|
ɪɢɞ+ɤɚɥɶɰɢɹ ɯɥɨ- |
|
|
|
|
|
|
|
ɪɢɞ+ɧɚɬɪɢɹ ɯɥɨ- |
|
|
|
|
|
|
|
ɪɢɞ+ɧɚɬɪɢɹ ɥɚɤɬɚɬ — |
|
|
|
|
|
|
|
ɪɚɫɬɜɨɪ ɏɚɪɬɦɚɧɚ) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
II. ɉɥɚɡɦɨɡɚɦɟɳɚɸɳɢɟ ɩɪɟɩɚɪɚɬɵ |
|
|
|
|
||
|
|
Ⱦɟɤɫɬɪɚɧ [ɫɪɟɞɧɹɹ ɦɨ- |
400 ɦɥ |
Ɇɚɤɫɢ- |
ɜ/ɜ ɤɚɩɟɥɶɧɨ |
|
|
|
|
ɥɟɤɭɥɹɪɧɚɹ ɦɚɫɫɚ |
|
ɦɚɥɶɧɨ ɞɨ |
|
|
|
|
|
30 000–40 000] («Ɋɟɨ- |
|
1500 |
|
|
|
|
|
ɩɨɥɢɝɥɸɤɢɧ») ɪ-ɪ |
|
ɦɥ/ɫɭɬ |
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
Ⱦɟɤɫɬɪɚɧ [ɫɪɟɞɧɹɹ ɦɨ- |
400 ɦɥ |
Ɇɚɤɫɢ- |
ɜ/ɜ ɤɚɩɟɥɶɧɨ |
|
|
|
|
ɥɟɤɭɥɹɪɧɚɹ ɦɚɫɫɚ |
|
ɦɚɥɶɧɨ ɞɨ |
|
|
|
|
|
|
|
|
|
|
|
178
6 Раздел
Ɂɚɛɨɥɟɜɚɧɢɟ, |
|
Ʌɟɤɚɪɫɬɜɟɧɧɵɟ |
Ɋɚɡɨɜɚɹ |
ɋɭɬɨɱɧɚɹ |
ɋɩɨɫɨɛ |
Ⱦɥɢɬɟɥɶɧɨɫɬɶ |
ɉɪɢɦɟɱɚɧɢɟ |
ɨɫɧɨɜɧɨɣ |
|
ɩɪɟɩɚɪɚɬɵ (Ʌɋ) |
ɞɨɡɚ |
ɞɨɡɚ |
ɜɜɟɞɟɧɢɹ |
ɬɟɪɚɩɢɢ |
|
ɜɨɡɛɭɞɢɬɟɥɶ |
|
|
|
|
|
|
|
|
|
50 000–70 000] («ɉɨɥɢ- |
|
2000 |
|
|
|
|
|
ɝɥɸɤɢɧ») ɪ-ɪ |
|
ɦɥ/ɫɭɬ |
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
Ⱦɟɤɫɬɪɚɧ [ɫɪɟɞɧɹɹ ɦɨ- |
400 ɦɥ |
Ɇɚɤɫɢ- |
ɜ/ɜ ɤɚɩɟɥɶɧɨ |
|
|
|
|
ɥɟɤɭɥɹɪɧɚɹ ɦɚɫɫɚ |
|
ɦɚɥɶɧɨ ɞɨ |
|
|
|
|
|
30 000– 40 000] («Ɋɟɨ- |
|
1500 |
|
|
|
|
|
ɦɚɤɪɨɞɟɤɫ») |
|
ɦɥ/ɫɭɬ |
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
Ƚɢɞɪɨɤɫɢɷɬɢɥɤɪɚɯɦɚɥ |
250–500 ɦɥ |
500 ɦɥ |
ɜ/ɜ ɤɚɩɟɥɶɧɨ |
|
|
|
|
6–10% ɪ-ɪ («Ɋɟɮɨɪɬɚɧ |
|
|
|
|
|
|
|
ȽɗɄ») |
|
|
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
Ⱥɥɶɛɭɦɢɧ 10% ɪ-ɪ |
100 ɦɥ |
100– |
ɜ/ɜ ɤɚɩɟɥɶɧɨ |
|
|
|
|
|
|
200 ɦɥ |
|
|
|
|
III. ɉɪɟɩɚɪɚɬɵ ɞɥɹ ɞɟɝɢɞɪɚɬɚɰɢɢ ɢ ɞɟɡɢɧɬɨɤɫɢɤɚɰɢɢ |
|
|
|
|||
|
|
Ⱦɟɤɫɬɪɨɡɚ 5% ɪ-ɪ |
400 ɦɥ |
400– |
ɜ/ɜ ɤɚɩɟɥɶɧɨ |
|
|
|
|
ɢɥɢ |
|
800 ɦɥ |
|
|
|
|
|
ɉɨɜɢɞɨɧ 8000+ɧɚɬɪɢɹ |
200–400 ɦɥ |
200– |
ɜ/ɜ ɤɚɩɟɥɶɧɨ |
|
|
|
|
ɯɥɨɪɢɞ+ɤɚɥɢɹ ɯɥɨ- |
|
400 ɦɥ |
|
|
|
|
|
ɪɢɞ+ɤɚɥɶɰɢɹ ɯɥɨ- |
|
|
|
|
|
|
|
ɪɢɞ+ɦɚɝɧɢɹ ɯɥɨ- |
|
|
|
|
|
|
|
ɪɢɞ+ɧɚɬɪɢɹ ɝɢɞɪɨɤɚɪ- |
|
|
|
|
|
|
|
ɛɨɧɚɬ («Ƚɟɦɨɞɟɡ-ɇ») |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
IV. |
ɉɪɟɩɚɪɚɬɵ ɞɥɹ ɩɚɪɟɧɬɟɪɚɥɶɧɨɝɨ ɩɢɬɚɧɢɹ (ɪɚɫɬɜɨɪɵ ɚɦɢɧɨɤɢɫɥɨɬ, ɷɥɟɤɬɪɨɥɢɬɨɜ, ɜɢɬɚɦɢ- |
|
||||
|
ɧɨɜ ɢ ɞɪ.) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
«ȼɚɦɢɧ 14» |
500 ɦɥ |
500 ɦɥ |
ɜ/ɜ |
|
|
179 ...заболеваний инфекционных терапии при применяемые ЛС,
Ɂɚɛɨɥɟɜɚɧɢɟ, |
|
Ʌɟɤɚɪɫɬɜɟɧɧɵɟ |
Ɋɚɡɨɜɚɹ |
ɋɭɬɨɱɧɚɹ |
ɋɩɨɫɨɛ |
Ⱦɥɢɬɟɥɶɧɨɫɬɶ |
ɉɪɢɦɟɱɚɧɢɟ |
ɨɫɧɨɜɧɨɣ |
|
ɩɪɟɩɚɪɚɬɵ (Ʌɋ) |
ɞɨɡɚ |
ɞɨɡɚ |
ɜɜɟɞɟɧɢɹ |
ɬɟɪɚɩɢɢ |
|
ɜɨɡɛɭɞɢɬɟɥɶ |
|
|
|
|
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
«Ⱥɦɢɧɨɫɬɟɪɢɥ Ʉȿ» |
500 ɦɥ |
500 ɦɥ |
ɜ/ɜ |
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
«ɇɟɮɪɚɦɢɧ» |
500 ɦɥ |
500 ɦɥ |
ɜ/ɜ |
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
«ɂɧɮɟɡɨɥ 100» |
500 ɦɥ |
500 ɦɥ |
ɜ/ɜ |
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
«Ⱥɦɢɧɨɩɥɚɡɦɚɥɶ ȿ» |
|
ɞɨ 3 ɝ/ɤɝ |
ɜ/ɜ |
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
ɋɨɟɜɵɯ ɛɨɛɨɜ ɦɚɫ- |
|
ɞɨ 100 ɝ |
ɜ/ɜ |
|
|
|
|
ɥɨ+ɬɪɢɝɥɢɰɟɪɢɞɵ |
|
(ɠɢɪ) |
|
|
|
|
|
(«Ʌɢɩɨɮɭɧɞɢɧ |
|
|
|
|
|
|
|
ɆɋɌ/ɅɋɌ» 10, 20%) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
V. |
ɉɪɟɩɚɪɚɬɵ ɞɥɹ ɤɨɪɪɟɤɰɢɢ |
ɝɢɩɨɤɚɥɢɟɦɢɢ |
|
|
|
ȼ 400 ɦɥ 5% ɪ-ɪɚ |
|
|
Ʉɚɥɢɹ ɢ ɦɚɝɧɢɣ ɚɫɩɚɪɚ- |
30–60 ɦɥ |
30–60 ɦɥ |
ɜ/ɜ |
|
ɝɥɸɤɨɡɵ |
|
|
ɝɢɧɚɬ («ɉɚɧɚɧɝɢɧ») |
|
|
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
Ʉɚɥɢɹ ɯɥɨɪɢɞ 3–4% |
60 ɦɥ |
60 ɦɥ |
ɜ/ɜ |
|
|
|
|
ɉɊȿɉȺɊȺɌɕ, ɋɌɂɆɍɅɂɊɍɘɓɂȿ ɆɈɌɈɊɂɄɍ ɀɄɌ |
|
|
|||
|
|
Ɇɟɬɨɤɥɨɩɪɚɦɢɞ («ɐɟ- |
10 ɦɝ |
20–40 ɦɝ |
ɜ/ɜ, ɜ/ɦ |
|
|
|
|
ɪɭɤɚɥ») |
|
|
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
Ⱦɢɫɬɢɝɦɢɧɚ ɛɪɨɦɢɞ |
0,5–1 ɦɝ |
0,5–1 ɦɝ |
ɜ/ɦ, ɩ/ɤ |
|
|
|
|
(«ɍɛɪɟɬɢɞ») |
|
|
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
ɇɟɨɫɬɢɝɦɢɧɚ ɦɟɬɢɥ- |
0,5 ɦɝ |
1–1,5 ɦɝ |
ɜ/ɦ, ɩ/ɤ |
|
|
|
|
|
|
|
|
|
|
180
6 Раздел
Ɂɚɛɨɥɟɜɚɧɢɟ, |
|
Ʌɟɤɚɪɫɬɜɟɧɧɵɟ |
Ɋɚɡɨɜɚɹ |
ɋɭɬɨɱɧɚɹ |
ɋɩɨɫɨɛ |
Ⱦɥɢɬɟɥɶɧɨɫɬɶ |
ɉɪɢɦɟɱɚɧɢɟ |
ɨɫɧɨɜɧɨɣ |
|
ɩɪɟɩɚɪɚɬɵ (Ʌɋ) |
ɞɨɡɚ |
ɞɨɡɚ |
ɜɜɟɞɟɧɢɹ |
ɬɟɪɚɩɢɢ |
|
ɜɨɡɛɭɞɢɬɟɥɶ |
|
|
|
|
|
|
|
|
|
ɫɭɥɶɮɚɬ («ɉɪɨɡɟɪɢɧ») |
|
|
|
|
|
|
ɉɊȿɉȺɊȺɌɕ, ɋɇɂɀȺɘɓɂȿ ɋȿɄɊȿɐɂɘ |
|
|
|
|||
|
ɠɟɥɭɞɤɚ: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ɏɚɦɨɬɢɞɢɧ («Ʉɜɚɦɚ- |
0,02 ɝ |
0,04 ɝ |
ɜɧɭɬɪɶ |
|
|
|
|
ɬɟɥ») |
|
|
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
Ɉɦɟɩɪɚɡɨɥ |
0,02–0,04 ɝ |
0,04–0,08 ɝ |
ɜɧɭɬɪɶ |
|
|
|
|
|
|
|
|
|
|
|
|
ɩɨɞɠɟɥɭɞɨɱɧɨɣ ɠɟɥɟɡɵ: |
|
|
|
|
|
|
|
Ɉɤɬɪɟɨɬɢɞ («ɋɚɧɞɨɫɬɚ- |
|
ɞɨ 200 ɦɤɝ |
ɜ/ɜ |
|
|
|
|
ɬɢɧ») |
|
|
|
|
|
|
|
ȺɇɌɂɄɈȺȽɍɅəɇɌɕ |
|
|
|
|
|
|
|
Ƚɟɩɚɪɢɧ ɧɚɬɪɢɹ |
5000 ȿȾ |
15 000– |
ɩ/ɤ |
|
|
|
|
ɢɥɢ |
|
20 000 ȿȾ |
|
|
|
|
|
Ⱦɚɥɬɟɩɚɪɢɧ ɧɚɬɪɢɹ |
0,3 ɦɥ |
0,3–0,6 ɦɥ |
ɩ/ɤ |
|
|
|
|
(«Ɏɪɚɝɦɢɧ») |
|
|
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
ɇɚɞɪɨɩɚɪɢɧ ɤɚɥɶɰɢɹ |
0,3 ɦɥ |
0,3–0,6 ɦɥ |
ɩ/ɤ |
|
|
|
|
(«Ɏɪɚɤɫɢɩɚɪɢɧ») |
|
|
|
|
|
|
|
ɢɥɢ |
|
|
|
|
|
|
|
ɗɧɨɤɫɚɩɚɪɢɧ ɧɚɬɪɢɹ |
0,2 ɦɥ |
0,2 ɦɥ |
ɩ/ɤ |
|
|
|
|
(«Ʉɥɟɤɫɚɧ») |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
ɋȿɊȾȿɑɇɈ-ɋɈɋɍȾɂɋɌȺə |
ɌȿɊȺɉɂə |
|
|
|
|
|
I. Ƚɥɢɤɨɡɢɞɵ |
|
|
|
|
|
|
|
|
Ⱦɢɝɨɤɫɢɧ |
|
0,25–0,5 ɦɝ |
ɜ/ɜ |
|
|
|
II. |
Ʉɚɪɞɢɨɬɨɧɢɱɟɫɤɢɟ ɩɪɟ- |
|
|
|
|
|
|
ɩɚɪɚɬɵ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
181 ...заболеваний инфекционных терапии при применяемые ЛС,